$1.03
+0 (+0%)
At Close: Oct 30, 2023
NEW YORK, Sept. 2, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc.
SPPI DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the Spectrum Pharmaceuticals, Inc. Class Action Lawsuit
09:34am, Thursday, 02'nd Sep 2021
SAN DIEGO, Sept. 2, 2021 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the Spectrum Pharmaceuticals class action lawsuit charges Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) and cer
Los Angeles, California--(Newsfile Corp. - September 2, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmac
NEW YORK, Sept. 1, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who
LOS ANGELES--(BUSINESS WIRE)---- $SPPI #SPPI--SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc.
LAWSUIT FILED: SPECTRUM PHARMACEUTICALS Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information
08:02am, Wednesday, 01'st Sep 2021
Boston, Massachusetts--(Newsfile Corp. - September 1, 2021) - Block & Leviton announces that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) for potential s
Pomerantz Law Firm Announces the Filing of a Class Action Against Spectrum Pharmaceuticals, Inc and Certain Officers - SPPI
10:16pm, Tuesday, 31'st Aug 2021
NEW YORK, Aug. 31, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc ("Spectrum" or the "Company") (NASDAQ: SPPI) and certai
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI
06:16pm, Tuesday, 17'th Aug 2021
New York, New York--(Newsfile Corp. - August 17, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI).
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Joe Turgeon on Q2 2021 Results - Earnings Call Transcript
07:07pm, Thursday, 12'th Aug 2021
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Joe Turgeon on Q2 2021 Results - Earnings Call Transcript
Spectrum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Update
04:05pm, Thursday, 12'th Aug 2021
HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI--Spectrum Pharmaceuticals (SPPI), a biopharma company focused on novel and targeted oncology therapies, reports results for 2Q2021 and a corp update.
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Spectrum Pharmaceuticals, Inc. (“Spectrum” or
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI
08:33pm, Monday, 09'th Aug 2021
NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI). Such investor
(SPPI) Alert: Did You Lose Money on Your Investment? Contact Johnson Fistel Regarding Investigation
01:06pm, Friday, 06'th Aug 2021
SAN DIEGO, Aug. 6, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Spectrum Pharmaceuticals, Inc. ("Spectru
Boston, Massachusetts--(Newsfile Corp. - August 6, 2021) - Block & Leviton is investigating Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) for potential securities law violations. Investors who have lo
BeyondSpring's Plinabulin: Upcoming PDUFA And Positioning In The CIN Space
11:00pm, Saturday, 31'st Jul 2021
BeyondSpring's Plinabulin: Upcoming PDUFA And Positioning In The CIN Space
Sign In
Buy SPPI